Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000705844 | SCV000834861 | uncertain significance | Gastrointestinal stromal tumor | 2023-03-13 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 581893). This variant has not been reported in the literature in individuals affected with KIT-related conditions. This variant is present in population databases (rs781588289, gnomAD 0.004%). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 696 of the KIT protein (p.Asp696Asn). |
Ambry Genetics | RCV002422605 | SCV002726555 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-14 | criteria provided, single submitter | clinical testing | The p.D696N variant (also known as c.2086G>A), located in coding exon 14 of the KIT gene, results from a G to A substitution at nucleotide position 2086. The aspartic acid at codon 696 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |